Some studies suggest that the serum levels of IL-6 and TNF-α are higher in CM patients than in EM patients [130,134,144], although Rozen and Swidan described a substantial rise in TNF-α levels in the CSF, but not serum, of CM patients when compared to HC [145]. This evidence concerns the gene IL6 and cutaneous mastocytosis.